News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Solexa Ltd. (SLXA) Strengthens Patent Position In Next-Generation Genetic Analysis



11/10/2005 6:16:37 PM

Solexa, Inc. (Nasdaq:SLXA) today announced two significant additions to its intellectual property (IP) portfolio. These advances relate to the use of reversible-terminator chemistry in DNA Sequencing-by-Synthesis (SBS) using either single molecules or clonal single molecules. The allowed claims combine with the company's existing patent portfolio, which has been bolstered throughout the year by both internal developments and acquisition of key IP, to significantly enhance Solexa's position in the field of SBS using amplified or non-amplified single molecule arrays.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES